Brief: Qiagen And Myriad Genetics Partner To Advance Companion Diagnostics Development For Cancer
26/10/2023 13:27
Oct 26 (Reuters) - Myriad Genetics Inc MYGN.O :
* QIAGEN AND MYRIAD GENETICS PARTNER TO ADVANCE COMPANION
DIAGNOSTICS DEVELOPMENT FOR CANCER
Source text for Eikon: ID:nGNX8ktjQx
Further company coverage: MYGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple